)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Shimadzu
Shimadzu (7701) investor relations material
Shimadzu Q2 2027 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2027 earnings summary10 Nov, 2026
Executive summary
H1 FY2027 net sales rose 10.0% YoY to ¥281,984 million; operating profit increased 18.3% to ¥37,359 million and attributable net income rose 19.6% to ¥28,264 million.
Operating margin was 13.2%, up 0.9pt YoY; sales and operating income exceeded Q1 assumptions.
Semiconductor demand and biopharmaceutical investment supported growth; the full-year forecast was revised upward.
Financial highlights
Ordinary profit rose 23.5% to ¥38,729 million; EBITDA increased 16% to ¥48.5B and operating profit before goodwill and other intangible amortization rose 18.0% to ¥38,103 million.
H1 sales rose across all major regions: Japan +6%, overseas +13.0%, the Americas +13.7%, Europe +17.9%, China +5.2% and other Asia +21.5%.
Operating income benefited from higher sales (+¥4.1B), efficiency (+¥2.5B), value-added pricing (+¥3.5B) and tariff refunds (+¥1.2B); human-capital investment reduced profit by ¥3.7B.
Q2 sales grew 10% to ¥151.4B and operating income before amortization rose 19% to ¥23.5B; net income fell 5% to ¥14.9B. Ordinary income rose 1% to ¥20.2B.
Outlook and guidance
FY2027 forecast: sales ¥630,000 million, operating profit ¥84,000 million, ordinary profit ¥85,000 million, attributable profit ¥61,000 million and EPS ¥211.21.
Revised versus prior forecast: sales +¥10,000 million, operating profit +¥4,000 million, ordinary profit +¥4,000 million and attributable profit +¥2,000 million.
Operating profit before goodwill amortization forecast at ¥89,000 million, up 18.4% YoY; revisions reflect H1 progress and expanded semiconductor-related demand.
FY2027 annual dividend forecast increased to ¥72 per share from ¥69, including ¥28 interim and ¥44 year-end; payout ratio expected at 34.1%.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Shimadzu
- Pursuing rapid growth in life science and semiconductor markets with AI-driven, customer-focused solutions.7701
Investor presentation - Record sales, profit, and upward guidance driven by semiconductor demand and a major acquisition.7701Q1 2027
- Record sales and profits achieved, with FY2026 guidance projecting continued growth amid uncertainties.7701Q4 2026
- Record sales and profit growth, with sales guidance raised but profit guidance unchanged.7701Q3 2026
- Record H1 sales and profit, with upward guidance and strong AMI/AE performance.7701Q2 2026
- Record Q1 sales and profit, but net profit dropped 20.7% amid FX and global risks.7701Q1 2026
- Net sales up 7.1%, but operating profit fell 17% on higher costs and China weakness.7701Q1 2025
- Record sales and segment growth prompt upward revision of full-year outlook.7701Q2 2025
- Record sales streak continues, but profit outlook dims amid tariff and FX headwinds.7701Q4 2025
Next Shimadzu earnings date
Q3 20274 Feb, 2027
Shimadzu
Next Shimadzu earnings date
Q3 20274 Feb, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Shimadzu Corporation specializes in analytical and measuring instruments, including technologies for research and development and quality control in fields such as pharmaceuticals, environmental measurement, and life sciences. Shimadzu's medical systems division contributes significantly to the early detection and treatment of diseases worldwide. Additionally, the company provides vacuum industrial machinery for the semiconductor industry, hydraulic equipment as essential components for machinery and vehicles, aircraft equipment for safe flight operations and passenger comfort, marine devices for efficient marine development, and optical devices to enhance equipment performance. Shimadzu Corporation is headquartered in Kyoto, Japan, and its shares are listed on the Tokyo Stock Exchange.